Literature DB >> 3116954

Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.

R A Asherson1, D Mercey, G Phillips, N Sheehan, A E Gharavi, E N Harris, G R Hughes.   

Abstract

Four patients with recurrent stroke and multi-infarct dementia are presented in whom the dementia was progressive and severe. Three of the patients developed the dementia during the course of an illness which was punctuated by repeated episodes of cerebral infarction demonstrated by computed tomographic (CT) scans. The fourth patient presented with an illness dominated by progressive and deteriorating higher mental functions, which culminated in a major stroke 18 months later. Three patients fulfilled the American Rheumatism Association (ARA) criteria for the classification of systemic lupus erythematosus, the fourth had a 'lupus-like' disease. All had livedo reticularis, severe migraines, and also demonstrated antibodies to phospholipids. All four patients suffered deep vein thromboses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116954      PMCID: PMC1002208          DOI: 10.1136/ard.46.8.605

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  33 in total

1.  CEREBROVASCULAR ACCIDENTS AS THE INITIAL MAJOR MANIFESTATION OF LUPUS ERYTHEMATOSUS.

Authors:  A SILVERSTEIN
Journal:  N Y State J Med       Date:  1963-10-15

2.  Recurrent transient global amnesia in a case with cerebrovascular lesions and livedo reticularis (Sneddon Syndrome).

Authors:  E Rumpl; H Rumpl
Journal:  J Neurol       Date:  1979-08       Impact factor: 4.849

3.  Neuropsychiatric problems in systemic lupus erythematosus.

Authors:  R Bennett; G R Hughes; E G Bywaters; P J Holt
Journal:  Br Med J       Date:  1972-11-11

4.  Livedo reticularis and cerebrovascular accidents.

Authors:  S R Quimby; H O Perry
Journal:  J Am Acad Dermatol       Date:  1980-10       Impact factor: 11.527

5.  [Livedo reticularis with neurological symptoms (author's transl)].

Authors:  T Stamm; R C Schmidt; D Lubach
Journal:  Nervenarzt       Date:  1982-04       Impact factor: 1.214

6.  Livedo reticularis and cerebro-vascular disease.

Authors:  W P Stephens; I T Ferguson
Journal:  Postgrad Med J       Date:  1982-02       Impact factor: 2.401

7.  Livedo reticularis and neurological lesions.

Authors:  D J Thomas; J D Kirby; K E Britton; D J Galton
Journal:  Br J Dermatol       Date:  1982-06       Impact factor: 9.302

8.  Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955--1977.

Authors:  S G Ellis; M A Verity
Journal:  Semin Arthritis Rheum       Date:  1979-02       Impact factor: 5.532

9.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

Review 10.  [Neurological changes in livedo racemosa generalisata (Ehrmann). Case reports and review of the literature].

Authors:  D Lubach; T Stamm
Journal:  Hautarzt       Date:  1981-05       Impact factor: 0.751

View more
  30 in total

Review 1.  Antiphospholipid antibodies and cardiovascular disease.

Authors:  H L Beynon; M J Walport
Journal:  Br Heart J       Date:  1992-04

Review 2.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

3.  Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.

Authors:  R Cervera; J Font; A López-Soto; F Casals; L Pallarés; A Bové; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

4.  Prevalence of anticardiolipin antibodies in the elderly British population.

Authors:  K K Chakravarty; R E Gray; M Webley; M A Byron; J Wozniak
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

Review 5.  The antiphospholipid syndrome: a syndrome in evolution.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 6.  Systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

7.  Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.

Authors:  R A Fields; W L Sibbitt; H Toubbeh; A D Bankhurst
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

Review 8.  Anticardiolipin antibody.

Authors:  G R Hughes; M A Khamashta
Journal:  BMJ       Date:  1989-12-09

9.  Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate.

Authors:  G Valesini; R Priori; A Francia; G Balestrieri; A Tincani; P Airo; R Cattaneo; A Zambruni; B Troianello; M Chofflon
Journal:  Springer Semin Immunopathol       Date:  1994

10.  Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: a prospective study.

Authors:  G D Sebastiani; G Passiu; M Galeazzi; F Porzio; U Carcassi
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.